Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,884
datasets available to search
ShareScore release 0.9.0
Dataset results
2,884 results for “cancer resistance”
Safety and Efficacy Study of KX2-391 for Treatment of Bone-Metastatic, Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT01074138. IPD Sharing: Not stated. Countries: 1. Publications: 2.
3-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer
ClinicalTrials.gov study NCT00081276. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Enzalutamide With Lu PSMA-617 Versus Enzalutamide Alone in Men With Metastatic Castration-resistant Prostate Cancer
ClinicalTrials.gov study NCT04419402. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Liquid Biopsy-based Detection of Resistance to Targeted Therapy in Prostate Cancer Patients
ClinicalTrials.gov study NCT03601143. IPD Sharing: NO. Countries: 1. Publications: 1.
Resistance Training During Radiation Therapy for Pharyngeal or Laryngeal Cancer
ClinicalTrials.gov study NCT00827164. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Resistance vs. Aerobic Training on Breast Cancer Patients Undergoing Neoadjuvant Treatment
ClinicalTrials.gov study NCT05297773. IPD Sharing: NO. Countries: 1. Publications: 1.
Evaluation of Drug Resistance in Patients With Metastatic Breast Cancer
ClinicalTrials.gov study NCT00003253. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Observational Cohort Study to Describe and Compare the Use of Darolutamide, Enzalutamide and Apalutamide and How Well These Work in Men With Non-metastatic Castration-resistant Prostate Cancer (nmC
ClinicalTrials.gov study NCT06013475. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy of Plasmid Elenagen in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Cancer
ClinicalTrials.gov study NCT05979298. IPD Sharing: NO. Countries: 1. Publications: 2.
177Lu-LNC1011 in Patients with Metastatic Castration-resistant Prostate Cancer
ClinicalTrials.gov study NCT06250244. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 1b Study of Pegylated Liposomal Doxorubicin and Pembrolizumab in Endocrine-resistant Breast Cancer
ClinicalTrials.gov study NCT03591276. IPD Sharing: NO. Countries: 1. Publications: 4.
Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT)
ClinicalTrials.gov study NCT06216249. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial of Abiraterone Acetate Plus LHRH-therapy Versus Abiraterone Acetate Sparing LHRH-therapy in Patients With Progressive Chemotherapy-naïve Castration-resistant Prostate Cancer (SPARE)
ClinicalTrials.gov study NCT02077634. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Cabazitaxel vs Abiraterone or Enzalutamide in Patients With Poor Prognosis Metastatic Castration-resistant Prostate Cancer
ClinicalTrials.gov study NCT02254785. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer
ClinicalTrials.gov study NCT03949283. IPD Sharing: NO. Countries: 1. Publications: 2.
Apatinib Combined With PLD vs PLD for Platinum-resistant Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT04348032. IPD Sharing: NO. Countries: 1. Publications: 3.
Safety and Pharmacokinetics of ODM-208 in Patients With Metastatic Castration-resistant Prostate Cancer
ClinicalTrials.gov study NCT03436485. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Efficacy and Resistant Mechanism of Eribulin and Bevacizumab for Advanced HER2 Negative Breast Cancer
ClinicalTrials.gov study NCT06539559. IPD Sharing: YES. Countries: 1. Publications: 8.
Study to Evaluate the Safety and Tolerability of CC-94676 in Participants With Metastatic Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT04428788. IPD Sharing: YES. Countries: 1. Publications: 0.
Retrospective Study to Describe the Real-world Treatment Patterns and Associated Clinical Outcomes in Patients With Metastatic Castration-resistant Prostates Cancer
ClinicalTrials.gov study NCT04801186. IPD Sharing: YES. Countries: 8. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.